NCT02734069View on ClinicalTrials.gov

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

RecruitingOBSERVATIONAL

Enrollment

132

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions

Lung CancerSarcopeniaToxicity

Interventions

DRUG

Carboplatin

Patients will receive carboplatin according to the carboplatin area under the curve dose calculation for 2 cycles to evaluate toxicity.

Trial Locations (1)

14080

RECRUITING

Instituto Nacional de Cancerologia, Mexico City

All Listed Sponsors

lead

Instituto Nacional de Cancerologia de Mexico

OTHER

NCT02734069 - Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC | Biotech Hunter | Biotech Hunter